
ABOUT CENCORA PHARMALEX
Beginning in January 2024, companies in the PharmaLex family started a journey of rebranding aligned with Cencora, our parent company and a leading global pharmaceutical solutions organization centered on improving lives around the world.
PharmaLex adds to Cencora’s expanding suite of pharma solutions and serves the pharma, biotech, and medtech industries. We guide clients from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-elevated solutions to support clients through the entire product lifecycle.
View our content to discover how our expanded capabilities can help you – or contact a Cencora PharmaLex expert today with any questions.
CONTACT INFORMATION
Cencora PharmaLex
1 W 1st Ave.
Conshohocken, PA 19428
UNITED STATES
FEATURED INSIGHTS
-
Experts discuss global market expansion, emphasizing regulatory complexities, product lifecycle investments, and integrating local expertise to ensure successful product launches and long-term market sustainability.
-
A new EU directive may require stricter environmental risk assessments for pharmaceuticals, impacting marketing authorization. Updated guidelines already in effect pose new challenges for companies.
-
By 2025 and beyond, AI, structured data, and real-world evidence will reshape the landscape, driving personalized medicine and more efficient processes. Here are eight key trends to watch.
GET MORE DETAILS ON OUR SOLUTIONS
-
Introducing the TMF Health Score – an expert methodology that provides an “early warning system” to commonly overlooked issues that often lead to inspection findings.
-
This precise, proven methodology delivers a high-quality migration of your Trial Master File to the destination system, typically just 4-6 weeks after receiving all documents from the source system.
-
Discover how intelligent, automated clinical trial safety reporting software can enhance compliance, reduce costs, and boost site responsiveness rates effortlessly.
-
PhlexTMF offers the industry’s only next-generation eTMF AI, providing expert suggestions at the critical document upload step, reducing errors, and improving TMF quality, completeness, and timeliness.
-
As deadlines loom for transitioning ongoing clinical trials in the EU to the Clinical Trials Regulation (CTR), understanding key timelines and dates becomes critical.
-
Explore the top 3 insights on the impact of pre-approval communication and learn why healthcare decision makers want more pre-approval resources and engagement from manufacturers.
EXPLORE OUR THOUGHT LEADERSHIP
Explore the latest insights from the Cencora team.
WHITE PAPERS
-
Digital Innovation In Pharmacovigilance
Explore how AI can transform your pharmacovigilance efforts and enhance patient safety by leveraging the insights and decision framework outlined here.
-
Mastering The Complexities Of Targeted Medicines
Explore the challenges and strategies involved in developing targeted medicines, with insights into the complexities, collaborations, and considerations necessary for success.
-
20 Years Of Biosimilars: Are We On The Right Track?
Explore the transformative journey of biosimilars, 20 years in. Through industry expert insights collected from a recent panel discussion, explore regulatory hurdles, market shifts, and the path ahead.
PODCASTS
-
Navigating The Digital Era And Beyond For Engaging Key Decision Makers In Specialty Pharmacy
Tune in as experts discuss how biopharma companies can effectively engage healthcare decision-makers in the evolving digital landscape.
-
Exploring The Interactions Between Validation, Technology Transfer
Listen as Gerardo Gomez delves into the intricate relationship between validation and technology transfer, taking into account the perspectives and standards set by regulators.
-
Early Access Programs: What They Are And How To Plan For Them
Explore how early access programs are tailored to individual sufferers of rare, ultra-rare, or life-threatening conditions, as well as cohort programs, which target groups of patients afflicted with the same disease.
WEBINARS
-
Driving Product Launch Success In Europe
Explore key steps for preparing your medicinal product for the European market, including insights on challenges, timelines, and a success story.
-
Harnessing The Power Of AI In Health Evidence Generation Strategy
Explore applications and limitations for artificial intelligence (AI) in healthcare as decision-makers determine whether to adopt the software in their environments.
-
TMF SUMMER SHORTS: House Of The Inspector
Discover key steps you can take to not just survive an inspection, but take the TMF Throne.
E-BOOKS AND OTHER INSIGHTS
-
How Patient-Centric Approaches Are Shaping The Future Of CGT
Emily Whitehead’s CAR-T cell therapy journey highlights the power of patient engagement in cell and gene therapies. Discover how her story and advocacy drive a patient-centric approach in innovative treatments.
-
A Comparative Guide To CGTs: Modalities, Landscape, And Logistics
Cell and gene therapies (CGTs) have the potential to revolutionize medicine. However, achieving therapeutic success requires advanced logistical consideration to ensure product safety and efficacy
-
Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And Solutions
Explore critical logistical requirements in autologous cell therapies logistics and learn how to overcome challenges and achieve successful and timely autologous cell therapy trials.